An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis | MicrobiomeTrials← Back to trialsNCT06398626
An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis
RecruitingOBSERVATIONAL
Trial Details
Start: 2024-09-17Est. Completion: 2027-10-01
Enrollment target: 300 participants Locations- Reddy GI Associates, Mesa, Arizona, United States
- Scripps Clinic Torrey Pines, La Jolla, California, United States
- United Medical Doctors, Los Alamitos, California, United States
- United Medical Doctors, Los Alamitos, California, United States
- Rocky Mountain Gastroenterology, Littleton, Colorado, United States
- Digestive and Liver Center of Florida Kissimmee, Kissimmee, Florida, United States
- Gastro Florida, Lutz, Florida, United States
- Gastro Florida, Lutz, Florida, United States
- Orlando Health/Digestive Health Institute, Orlando, Florida, United States
- Feinberg School of Medicine Northwestern University, Chicago, Illinois, United States
- Rush University Medical Center, Chicago, Illinois, United States
- Suburban Gastroenterology Ltd, Naperville, Illinois, United States
- MGG Group Co., Inc., Chevy Chase Clinical Research, Chevy Chase, Maryland, United States
- Woodholme Gastroenterology Associates PA, Glen Burnie, Maryland, United States
- Virtua Health, Marlton, New Jersey, United States
- NYU Langone Health, New York, New York, United States
Other microbiome trials you might be interested in
Inflammatory Bowel Diseases (IBD)Crohn DiseaseColitis, Ulcerative
Difficult-to-treat inflammatory bowel disease (DTT-IBD) represents a heterogeneous group of patients with treatment-refr…
Multiple LocationsEst. completion Oct 31, 2032
Inflammatory Bowel Disease
This study evaluates oral Lactobacillus reuteri as an adjunct therapy for 2 months. Endoscopic assessments will be perfo…
Suqian, ChinaCompleted Mar 30, 2026
Lenox Hill Hospital, Northwell Health, New York, New York, United StatesUniversity of North Carolina at Chapel Hill, Division of Gastroenterology and Hepatology, Chapel Hill, North Carolina, United StatesOnSite Clinical Solutions, LLC, Charlotte, North Carolina, United StatesUniversity of Cincinnati College of Medicine, Cincinnati, Ohio, United StatesGastro Intestinal Research Institute of Northern Ohio, LLC, Westlake, Ohio, United StatesMedical University of South Carolina (MUSC), Charleston, South Carolina, United StatesHouston Endoscopy & Research Center, Houston, Texas, United StatesBI Research Center, Houston, Texas, United StatesBrooke Army Medical center, San Antonio, Texas, United StatesBrooke Army Medical center, San Antonio, Texas, United StatesGI Alliance Research, Southlake, Texas, United StatesWashington Gastroenterology, Tacoma, Washington, United StatesWVU Medicine J.W Ruby Memorial Hospital, Morgantown, West Virginia, United StatesRecruiting
Recurrent C. Difficile (rCDI)Ulcerative Colitis (UC)Metabolic Syndrome (MetS)
The gut microbiota plays a key role in immunity and metabolism and contributes to diseases such as recurrent C. difficil…
Rome, ItalyEst. completion Jan 19, 2029